E

Surgery Partners, Inc. SGRY

$13.35 -$0.58-4.16% NASDAQ
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

Company Overview

Surgery Partners, Inc. is a healthcare services company focused on short-stay surgical care and ancillary services in the United States. The company operates primarily in the outpatient healthcare industry through a network of ambulatory surgery centers (ASCs), surgical hospitals, physician practices, and related ancillary services. Surgery Partners generates revenue mainly from surgical procedures performed in its facilities, with additional contributions from anesthesia services, diagnostic testing, physician services, and other healthcare support operations. The company serves patients, physicians, managed care organizations, and government healthcare programs, with a significant concentration in elective and minimally invasive procedures across multiple specialties.

The company traces its origins to a series of physician-partnered surgery center investments and was formally established in its current structure in 2014 through the combination of several outpatient surgery businesses backed by private equity investors. Surgery Partners later became publicly traded on the Nasdaq under the ticker SGRY. Its strategic positioning is centered on physician alignment, cost-efficient outpatient care delivery, and the ongoing migration of procedures from inpatient hospital settings to lower-cost ambulatory environments. Industry positioning has been reinforced by scale, payer relationships, and operational expertise in managing multi-site surgical networks.

Business Operations

Surgery Partners operates through integrated outpatient healthcare platforms that include Ambulatory Surgical Centers, Surgical Facilities, Physician Practices, and ancillary healthcare operations. The company earns revenue primarily through facility fees associated with surgical procedures, with orthopedic, gastroenterology, ophthalmology, pain management, and cardiovascular specialties representing important procedural categories. The company also operates diagnostic laboratories, anesthesia services, and specialty physician practices that support procedural volume and care coordination.

Operations are concentrated in the United States, with facilities located across numerous states and metropolitan markets. Surgery Partners maintains ownership interests in many of its facilities alongside physician partners, a structure that aligns incentives between surgeons and operators. The company controls a broad portfolio of healthcare assets, including licensed surgical facilities, operating room infrastructure, clinical management systems, and payer contracting relationships. Strategic relationships with health systems and physician groups have supported market expansion, while acquisitions of regional surgery center platforms and physician-aligned facilities have contributed to growth.

Strategic Position & Investments

Surgery Partners’ strategic direction emphasizes expanding outpatient procedural capacity, increasing same-store surgical volume, and benefiting from healthcare system migration toward lower-cost ambulatory settings. The company has pursued acquisitions and de novo facility development to increase density in targeted markets. Growth initiatives have also included expanding high-acuity outpatient procedures that historically occurred in hospitals, particularly in orthopedics and cardiovascular care. Public filings and investor materials indicate that management views physician alignment and payer cost efficiency as core competitive advantages.

The company has completed multiple acquisitions of ambulatory surgery centers and related healthcare operations over time, including regional ASC platforms and physician-integrated facilities. Surgery Partners has also maintained partnerships with physicians and health systems through joint ventures and minority ownership structures. The company continues to invest in clinical technology, operational optimization, and facility expansion intended to support procedure growth and margin improvement. Its portfolio strategy is focused on fragmented outpatient healthcare markets where scale and payer relationships may improve operational leverage.

Geographic Footprint

Surgery Partners is headquartered in Brentwood, Tennessee, and operates facilities throughout the United States. Its network spans multiple states, with meaningful operational presence in regions including the Southeast, Southwest, Midwest, and selected urban markets nationwide. The company’s facilities are generally concentrated in metropolitan and suburban areas with growing demand for outpatient surgical services.

Although Surgery Partners does not maintain significant international healthcare operations, its influence is tied to the broader U.S. outpatient surgical market, which has experienced structural growth driven by payer incentives and procedural migration trends. The company’s market presence is supported through regional clustering strategies, physician partnerships, and relationships with commercial insurers and government healthcare programs across numerous geographic markets.

Leadership & Governance

Surgery Partners is governed by a management team with backgrounds in healthcare operations, finance, and physician practice management. Leadership strategy has emphasized disciplined expansion, physician partnership models, operational efficiency, and long-term participation in the outpatient surgery market. Public disclosures and investor communications indicate a focus on balancing acquisitive growth with margin performance and clinical quality initiatives.

Key executives include:

  • Eric Evans – Chief Executive Officer
  • David T. Doherty – Chief Financial Officer
  • Richard D. Chesher – Chief Operating Officer
  • Celeste C. Murphy – Executive Vice President, General Counsel and Secretary
  • Thomas E. Cowhey – Group President

Information in this overview is based on publicly available company disclosures, including SEC filings, investor presentations, earnings materials, and reporting from major financial and healthcare industry publications. Where operational details varied among public sources, information was limited to consistently reported facts.

Data compiled by narrative technology. May contain errors.

Top Tech Stocks
See All »
B
NVDA NASDAQ $219.34
B
AAPL NASDAQ $337.00
B
AVGO NASDAQ $347.30
Top Consumer Staple Stocks
See All »
B
WMT NASDAQ $106.79
A
Top Financial Stocks
See All »
B
B
JPM NYSE $349.31
B
V NYSE $369.93
Top Health Care Stocks
See All »
B
LLY NYSE $1,152.44
B
JNJ NYSE $270.22
B
ABBV NYSE $264.02
Top Real Estate Stocks
See All »
B
PLD NYSE $135.18
B
EQIX NASDAQ $1,025.94